Insider · CIK 0001971421
Bernhardt G Zeiher
Files at ABEO (ABEONA THERAPEUTICS INC.), AMLX (Amylyx Pharmaceuticals, Inc.), TRDA (Entrada Therapeutics, Inc.). First filing Mar 24, 2025, latest Mar 24, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
AMLX: Amylyx Pharmaceuticals, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 37Weak | AMLXbuy Amylyx Pharmaceuticals, Inc. | $37k 10,000 shares | - | +50% from low-47% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2025 | TRDA Entrada Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Jun 12, 2025 |
| Jun 5, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | AGrant or award Stock Option (right to buy)derivative | +25,000 | $0.00 | $0 | 25,000 | Jun 9, 2025 |
| Mar 20, 2025 | AMLX Amylyx Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +10,000 | $3.70 | $37k | 10,000 | Mar 24, 2025 |
| Jan 31, 2025 | ABEO ABEONA THERAPEUTICS INC. | AGrant or award Common Stock | +36,101 | $0.00 | $0 | 47,145 | Feb 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.